Perifosine Completed Phase 2 Trials for Colon Cancer Treatment

Back to Perifosine
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00398879Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients